Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Rapport Therapeutics, Inc. Common Stock

RAPP Technical Analysis Summary (NASDAQ)

Analyze RAPP on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

RAPP●NASDAQ
HealthcareBiotechnology
$42.13
$1.45(3.56%)
U.S. Market opens in 14h 30m

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

RAPP Technical Analysis Summary (NASDAQ)

Rapport Therapeutics, Inc. Common Stock (NASDAQ: RAPP) stock currently shows a bullish trend on the NASDAQ, supported by momentum and strong buying pressure.

Overall Sentiment:Buy
Momentum:Neutral to Bullish (RSI: 54.12)
Trend Strength:Moderate (ADX: 27.48)
Volatility:High (ATR: 2.57)
Support/Resistance:$38.57 – $43.11 (Bollinger Bands)

Technical conditions suggest Rapport Therapeutics, Inc. Common Stock on the NASDAQ is awaiting a decisive move. This mix signals that Rapport Therapeutics, Inc. Common Stock is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 54.12

Bullish
Above midpoint suggests upward bias.

Stochastic %K: 46.21

Neutral
Mid-range signal with no clear trend.

Williams %R: -49.31

Neutral
Balanced market without strong signals.

Rate of Change (ROC): 4.28

Bullish
Steady upward momentum.

Takeaway:Rapport Therapeutics, Inc. Common Stock shows neutral momentum, with indicators pointing to indecision.

Trend & Volatility

MACD: 0.75

Bullish
Bullish, trend momentum is strengthening.

ADX: 27.48

Moderate
Moderate trend, direction gaining strength.

ATR (14): 2.57

Medium
Medium volatility, healthy price movement.

CCI (14): 71.13

Bullish
Bullish, momentum building upward.

Takeaway:Rapport Therapeutics, Inc. Common Stock shows strong upward trend with solid momentum and healthy volatility.

Support & Resistance indicators
Bollinger Bands
Upper Band
$43.11
Middle Band (SMA 20)
$40.84
Lower Band
$38.57
Current Position
Within Bands

Takeaway:Rapport Therapeutics, Inc. Common Stock trades closer to resistance, supported by stronger momentum within bands.

Keltner Channels
Upper Channel
$45.78
Middle Line (EMA 20)
$40.64
Lower Channel
$35.50
Squeeze Status
Squeeze On

Takeaway:Rapport Therapeutics, Inc. Common Stock trades above the trend line, showing healthy momentum within the channel.

Volume & Money Flow Analysis
On-Balance Volume6.06M
Money Flow Index65.82Bullish, inflows support continued momentum.
Relative Vigor Index56.75Neutral to Bullish, buyers hold a slight edge.

Overall Takeaway:RAPP shows bullish money flow, with volume and vigor supporting buyers.

Technical Trading Signals Summary
Based on the current technical analysis of Rapport Therapeutics, Inc. Common Stock (NASDAQ: RAPP), here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

ADX above 20 → strong underlying trend.

Price trading above middle Bollinger Band → mid-term support intact.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

Overall Recommendation:Technical indicators for Rapport Therapeutics, Inc. Common Stock are mixed, suggesting a Hold or wait-and-see approach.

(NASDAQ: RAPP) Technical Analysis FAQ